NEW ISSUE
Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...
Optimising the delivery of self-expanding valves according to vascular access
November 20, 2020
Showing 1-12 of 12 articles
FFR for CABG: not ready for prime time
December 6, 2019 | 10.4244/EIJV15I11A177
Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial
August 9, 2019 | 10.4244/EIJ-D-19-00263
Absence of proof or proof of absence? The risk of underpowered studies in cardiovascular medicine
September 20, 2018 | 10.4244/EIJV14I7A126
What is new in the armamentarium of coronary surgeons to compete with PCI?
July 20, 2018 | 10.4244/EIJV14I4A69
Coronary interventions
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial September 18, 2016 | 10.4244/EIJV12I7A141
Coronary interventions
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease June 10, 2016 | 10.4244/EIJV12I2A36
2014 ESC/EACTS Guidelines on myocardial revascularization
January 22, 2015 | 10.4244/EIJY14M09_01
Numbers needed to treat (lives!) and numbers needed to save (money)
June 28, 2013 | 10.4244/EIJV9I2A28
Does a hybrid approach to multivessel revascularisation really make sense?
March 22, 2013 | 10.4244/EIJV8I11A189